OMTX-001

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameOMTX-001
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta inhibitorsCathepsin B inhibitors
TargetsCathepsin BTransforming growth factor beta
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOncomatryx Biopharma Sl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOncomatryx Biopharma Sl
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A